DD232916A5 - Verfahren zur herstellung von 2-oxindol-1-carboxamiden oder pharmazeutisch akzeptabler salze hiervon - Google Patents

Verfahren zur herstellung von 2-oxindol-1-carboxamiden oder pharmazeutisch akzeptabler salze hiervon Download PDF

Info

Publication number
DD232916A5
DD232916A5 DD85275898A DD27589885A DD232916A5 DD 232916 A5 DD232916 A5 DD 232916A5 DD 85275898 A DD85275898 A DD 85275898A DD 27589885 A DD27589885 A DD 27589885A DD 232916 A5 DD232916 A5 DD 232916A5
Authority
DD
German Democratic Republic
Prior art keywords
carbons
alkyl
phenyl
oxindole
formula
Prior art date
Application number
DD85275898A
Other languages
German (de)
English (en)
Inventor
Saul B Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD232916A5 publication Critical patent/DD232916A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD85275898A 1984-05-04 1985-05-02 Verfahren zur herstellung von 2-oxindol-1-carboxamiden oder pharmazeutisch akzeptabler salze hiervon DD232916A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (1)

Publication Number Publication Date
DD232916A5 true DD232916A5 (de) 1986-02-12

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85275898A DD232916A5 (de) 1984-05-04 1985-05-02 Verfahren zur herstellung von 2-oxindol-1-carboxamiden oder pharmazeutisch akzeptabler salze hiervon

Country Status (25)

Country Link
JP (1) JPS60243068A (ru)
KR (1) KR870000497B1 (ru)
AR (1) AR241159A1 (ru)
BG (2) BG60208B2 (ru)
CS (1) CS252828B2 (ru)
DD (1) DD232916A5 (ru)
EG (1) EG17193A (ru)
ES (2) ES8609248A1 (ru)
FI (1) FI80016C (ru)
HU (1) HU196057B (ru)
IE (1) IE851103L (ru)
IN (1) IN161509B (ru)
MA (1) MA20424A1 (ru)
MW (1) MW1685A1 (ru)
MX (1) MX5839A (ru)
NO (1) NO163132C (ru)
OA (1) OA08098A (ru)
PL (2) PL147508B1 (ru)
PT (1) PT80375B (ru)
RO (2) RO91141B (ru)
RU (1) RU2017729C1 (ru)
SU (1) SU1468413A3 (ru)
YU (1) YU44998B (ru)
ZA (1) ZA853324B (ru)
ZW (1) ZW7885A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis

Also Published As

Publication number Publication date
HU196057B (en) 1988-09-28
FI80016B (fi) 1989-12-29
ES551275A0 (es) 1987-07-16
FI80016C (fi) 1990-04-10
MX5839A (es) 1993-11-01
BG60207B2 (en) 1993-12-30
PT80375A (en) 1985-05-01
NO851774L (no) 1985-11-05
YU73085A (en) 1988-04-30
JPH0335315B2 (ru) 1991-05-27
HUT37754A (en) 1986-02-28
ES8707182A1 (es) 1987-07-16
RO91141A (ro) 1987-06-30
KR870000497B1 (ko) 1987-03-12
FI851756L (fi) 1985-11-05
ES542813A0 (es) 1986-07-16
PT80375B (pt) 1987-09-30
RO91141B (ro) 1987-07-03
RO94455A (ro) 1988-06-30
RO94455B (ro) 1988-07-01
PL147508B1 (en) 1989-06-30
BG60208B2 (en) 1993-12-30
YU44998B (en) 1991-06-30
RU2017729C1 (ru) 1994-08-15
PL257892A1 (en) 1986-10-07
SU1468413A3 (ru) 1989-03-23
ES8609248A1 (es) 1986-07-16
JPS60243068A (ja) 1985-12-03
MW1685A1 (en) 1986-09-10
CS252828B2 (en) 1987-10-15
IE851103L (en) 1985-11-04
AR241159A2 (es) 1991-12-30
MA20424A1 (fr) 1985-12-31
NO163132B (no) 1990-01-02
ZW7885A1 (en) 1985-07-24
CS320285A2 (en) 1987-03-12
ZA853324B (en) 1986-12-30
PL145416B1 (en) 1988-09-30
AR241159A1 (es) 1991-12-30
FI851756A0 (fi) 1985-05-03
OA08098A (fr) 1987-03-31
NO163132C (no) 1990-04-11
EG17193A (en) 1990-08-30
KR850008154A (ko) 1985-12-13
IN161509B (ru) 1987-12-19
PL253203A1 (en) 1986-06-17

Similar Documents

Publication Publication Date Title
US4569942A (en) N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
US4556672A (en) 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE60204718T2 (de) 3-substituierte oxindol beta 3 agonisten
EP0175551B1 (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4721712A (en) 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
DD234417A5 (de) Verfahren zur herstellung von 1,3-disubstituerten 2-oxindoeln als analytische und entzuendungshemmende mittel
DD251971A5 (de) Verfahren zur herstellung einer pharmazeutisch aktiven oxindol-verbindung
EP0153818B1 (en) 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
DD232039A5 (de) Verfahren zur herstellung einer 2-oxinidol-1-carboxamid-verbindung
DD232916A5 (de) Verfahren zur herstellung von 2-oxindol-1-carboxamiden oder pharmazeutisch akzeptabler salze hiervon
US4665194A (en) Process for making 2-oxindole-1-carboxamides and intermediates therefor
EP0155828A2 (en) Process for making 2-oxindole-1-carboxamides and intermediates therefor
DD254001A5 (de) Verfahren zur herstellung von heterocyclischen oxophtalazinylessigsaeuren
US4752609A (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4808601A (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4730004A (en) Analgesic and anti-inflammatory 1-acyl-2-oxindole-3-carboxamides
US4791131A (en) Analgesic and antiinflammatory 1-acyl-2-oxindole-3-carboxamides
CA1287626C (en) N-substituted 2-ixindole-1-carboxamides useful as intermediates for producing analgesic and antiinflammatory agents
CA1289556C (en) 1- or 3-monosubstituted 2-oxindole compound intermediates useful for the production of analgesic and anti-inflammatory agents
CA1255657A (en) 1,3-disubstituted 2-oxindoles as analgesic and anti- inflammatory agents
DD232265A5 (de) Verfahren zur herstellung von 2-oxindol-1-carboxamiden und zwischenstufen dafuer
IE850288L (en) Analgesic oxindoles.
CS252847B2 (cs) Způsob výroby N,3-disubstituovaných 2-oxindol-1-karboxamidů
BG60375B2 (bg) Заместени на 3-то място 2-оксиндол-1-карбоксамиди като аналгетични и противовъзпалителни вещества

Legal Events

Date Code Title Description
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)
ENJ Ceased due to non-payment of renewal fee